Results - Announcements
Jenburkt Pharmaceuticals standalone net profit declines 8.91% in the December 2025 quarter As on : 03-Feb-26  17:59

Net profit of Jenburkt Pharmaceuticals declined 8.91% to Rs 5.93 crore in the quarter ended December 2025 as against Rs 6.51 crore during the previous quarter ended December 2024. Sales rose 16.62% to Rs 43.02 crore in the quarter ended December 2025 as against Rs 36.89 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	43.02	36.89	17
OPM %	17.27	23.94	-
PBDT	9.13	10.30	-11
PBT	8.30	9.52	-13
NP	5.93	6.51	-9

Powered by Capital Market - Live News